Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
Mallinckrodt
Merck
Argus Health
Cipla
US Army
Fuji
Harvard Business School
Accenture

Generated: January 17, 2018

DrugPatentWatch Database Preview

Griseofulvin, microcrystalline - Generic Drug Details

« Back to Dashboard

What are the generic sources for griseofulvin, microcrystalline and what is the scope of griseofulvin, microcrystalline patent protection?

Griseofulvin, microcrystalline
is the generic ingredient in three branded drugs marketed by Wyeth Ayerst, Johnson And Johnson, Chartwell Rx, J And J, and Valeant Luxembourg, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for griseofulvin, microcrystalline.

US Patents and Regulatory Information for griseofulvin, microcrystalline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst GRISACTIN griseofulvin, microcrystalline CAPSULE;ORAL 050051-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Luxembourg GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 062279-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 060618-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst GRISACTIN griseofulvin, microcrystalline TABLET;ORAL 060212-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Luxembourg GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 062279-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chartwell Rx FULVICIN-U/F griseofulvin, microcrystalline TABLET;ORAL 060569-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst GRISACTIN griseofulvin, microcrystalline CAPSULE;ORAL 050051-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 060618-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chartwell Rx FULVICIN-U/F griseofulvin, microcrystalline TABLET;ORAL 060569-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 060618-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Farmers Insurance
Citi
McKesson
McKinsey
Express Scripts
Daiichi Sankyo
Fish and Richardson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot